Publications

Members only publications are marked with a lock icon:
Filter By

Functional Status Is Associated With 30-Day Potentially Preventable Readmissions Following Skilled Nursing Facility Discharge Among Medicare Beneficiaries

JAMDA
January 19, 2018
The objectives of this study were to determine the association between patients’ functional status at discharge from skilled nursing facility (SNF) care and 30-day potentially preventable hospital readmissions, and to examine common reasons for...

Muscle Strength and Functional Limitations: Preserving Function in Older Mexican Americans

JAMDA
January 19, 2018
Understanding the role of muscle strength as a preventive factor for shorter-term declines in function may provide further insights into the disabling process. This study examined if muscle strength was associated with 2-year preservation of...

Research Priorities for Optimizing Geriatric Pharmacotherapy: An International Consensus

JAMDA
January 18, 2018
Medication management is becoming increasingly challenging for older people, and there is limited evidence to guide medication prescribing and administration for people with multimorbidity, frailty, or at the end of life. Currently, there is a lack...

Ethical and Practical Ways in Which MOELI (Medical Orders for End-of-Life Intervention) Advance the Physician Orders for Life-Sustaining Treatment (POLST) Program

JAMDA
January 9, 2018
We are pleased that Hickman et al,1 some of whom have done much of the heavy-lifting throughout the development of the Physician Orders for Life-Sustaining Treatment (POLST) program, offered their appraisal of our MOELI.2 They question the value or...

The Cost-Effectiveness of Using PARO, a Therapeutic Robotic Seal, to Reduce Agitation and Medication Use in Dementia: Findings from a Cluster–Randomized Controlled Trial

JAMDA
January 9, 2018
To examine the within-trial costs and cost-effectiveness of using PARO, compared with a plush toy and usual care, for reducing agitation and medication use in people with dementia in long-term care.

The Cost-Effectiveness of Using PARO, a Therapeutic Robotic Seal, to Reduce Agitation and Medication Use in Dementia: Findings from a Cluster–Randomized Controlled Trial

JAMDA
January 9, 2018
To examine the within-trial costs and cost-effectiveness of using PARO, compared with a plush toy and usual care, for reducing agitation and medication use in people with dementia in long-term care.

January 5, 2018

Weekly Roundup
Centers for Medicare and Medicaid (CMS), Dementia, Medication, Antipsychotics, Medication Management, Medicare Access and CHIP Re-authorization Act (MACRA), Merit-Based Incentive Program Payment System (MIPS), Physician Fee Schedule (PFS), Quality Payment Program (QPP), Practice Management, Quality
January 6, 2018
MEMBERS ONLY CONTENT Login or Join Spotlight: Expert Offers Guidance on Preparing to Care for Mentally Ill in PALTC HPA: Society Asks CMS to Reconsider ‘Resource’ Category in MIPS and Study Risk Adjustment Models; Practice Management and Leadership...

Online Training and Support Programs Designed to Improve Mental Health and Reduce Burden Among Caregivers of People With Dementia: A Systematic Review

JAMDA
January 4, 2018
Dementia poses a considerable socioeconomic burden to society. On a global scale, family and other unpaid care predominates. Supporting caregivers is crucial, but scalable interventions are currently lacking. Because a growing number of studies have...

Effects of Legal Access to Cannabis on Scheduled II–V Drug Prescriptions

Podcasts
End-of-Life Care, Hospice, Long-Term Care, Opioids, Depression, Pain Management, Right’s
January 4, 2018
In our first podcast , AMDA-On-The-Go host, Dr. Wayne Saltsman, MD, PhD, CMD, FACP, interviews Dr. Cari Levy, MD, PhD, CMD. The topic of discussion is the JAMDA article "Effects of Legal Access to Cannabis on Scheduled II–V Drug Prescriptions". Dr...

Antihypertensive Medication Regimen Intensity and Incident Dementia in an Older Population

JAMDA
January 3, 2018
To investigate the association between antihypertensive medication regimen intensity and risk of incident dementia in an older population.